LISATA THERAPEUTICS, INC. Finite-Lived Intangible Assets, Net
LISATA THERAPEUTICS, INC. (LSTA) had Finite-Lived Intangible Assets, Net of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-03-12
- 2025-12-31: Finite-Lived Intangible Assets, Net $0.00.
- 2025-09-30: Finite-Lived Intangible Assets, Net $139.00K.
- 2025-06-30: Finite-Lived Intangible Assets, Net $157.00K.
- 2025-03-31: Finite-Lived Intangible Assets, Net $174.00K.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $139.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $157.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $174.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $192.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $210.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $228.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $245.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $263.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $281.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $299.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $317.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $334.00K 10-Q · filed 2023-11-02 | |
| 2022-09-30 | $352.00K 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-10 | |
| 2017-03-31 | $2.17M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.31M 10-Q · filed 2017-05-15 | |
| 2016-09-30 | $2.45M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.45M 10-Q · filed 2016-11-07 | $2.59M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.74M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.88M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $37.71M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $37.86M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $47.41M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $47.56M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $47.71M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $49.36M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $13.72M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $13.88M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $14.03M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $14.18M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $14.33M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $14.48M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $14.63M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $14.78M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $15.09M 10-K · filed 2013-03-11 | |
| 2010-12-31 | $563.40K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |